Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Enrolling by invitation 1Completed 1

Sponsor Class

OTHER 37INDUSTRY 22NETWORK 6NIH 3OTHER_GOV 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 2

Conditions

Prostatic Neoplasms 3Breast Neoplasms 2Osteosarcoma 1Neoplasms by Site 1Neoplasms 1Multiple Myeloma 1Insulin Resistance 1Fatigue 1Breast Diseases 1

Interventions

Tamoxifen 10Docetaxel 8Trastuzumab 7Paclitaxel 6Letrozole 6Gemcitabine 6Exercise 6Control Groups 6exemestane 5Indocyanine Green 5Cyclophosphamide 5Carboplatin 5Anastrozole 5pertuzumab 4dalpiciclib 4Vinorelbine 4Doxorubicin 4Capecitabine 4pyrotinib 3Surgical Procedures, Operative 3Standard of Care 3Radiotherapy 3Radiation 3Mammography 3Fulvestrant 3Cisplatin 3ferumoxides 2Zoledronic Acid 2Tablets 2Surveys and Questionnaires 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER_GOV × Breast Neoplasms × Zoledronic Acid × Clear all
NCT04488614 2020-07-30

PBCB

Helse Stavanger HF

Enrolling by invitation
1,200 enrolled
Breast

Breast Neoplasms, Fatigue

NCT01472146 2017-05-09

ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer

Instituto Nacional de Cancer, Brazil

Phase 2 Completed
58 enrolled
Breast

Breast Diseases, Breast Neoplasms, Neoplasms, Neoplasms by Site

Data powered by HemOnc (CC BY 4.0) Colophon âš¡